ANI Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

ANI Pharmaceuticals

29/02/2024 14:31

* ANI Pharmaceuticals Inc  ANIP.OQ  reported quarterly
adjusted
earnings of $1.00​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of 76 cents.  The mean expectation of four analysts
for the quarter was for earnings of 86 cents per share. Wall
Street expected results to range from 74 cents to $1.01 per
share.
    * Revenue rose 39.7% to $131.65 million from a year ago;
analysts
expected $122.21 million. 
    * ANI Pharmaceuticals Inc's reported EPS for the quarter was
4
cents​.
    * The company reported quarterly net income of $749
thousand.
    * ANI Pharmaceuticals Inc shares had risen by 9.3% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 9.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for ANI
Pharmaceuticals Inc is $71.00 

This summary was machine generated from LSEG data February 29 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.86           1.00           Beat
 Sep. 30 2023      0.84           1.27           Beat
 Jun. 30 2023      0.68           1.28           Beat
 Mar. 31 2023      0.35           1.17           Beat